Iain D. Dukes, Director at Iovance Biotherapeutics, holds 54.00K shares in Iovance Biotherapeutics (Ticker: IOVA), holds ― shares in Ikena Oncology (Ticker: IKNA), holds 1.78M shares in Traws Pharma (Ticker: TRAW). Most recently, Iain D. Dukes Bought ― shares of Iovance Biotherapeutics on Feb 20, 2024 for an estimated value of 292.80K.
What is the percentage of profitable transactions made by Iain D. Dukes?
The percentage of profitable transactions made by Iain D. Dukes is 33%.
What is the average return per transaction made by Iain D. Dukes?
The average return per transaction made by Iain D. Dukes is 80.40%.
What stocks does Iain D. Dukes hold?
Iain D. Dukes holds: IOVA, IKNA, THRX, TRAW stocks.
What was Iain D. Dukes’s latest transaction?
Iain D. Dukes latest transaction was an Informative Buy of $292.80K.
What was Iain D. Dukes's most profitable transaction?
Iain D. Dukes’s most profitable transaction was an Informative Buy of IOVA stock on December 20, 2018. The return on the trade was 261.70%.
What is Iain D. Dukes's role in Iovance Biotherapeutics?
Iain D. Dukes's role in Iovance Biotherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.